X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,417 | -12.4% | 1,628,980 | 0.0% | 0.09% | -13.9% |
| Q4 2022 | $1,618 | -99.9% | 1,628,980 | +96.1% | 0.11% | +9.1% |
| Q3 2022 | $1,420,000 | +1320.0% | 830,654 | +698.9% | 0.10% | +1137.5% |
| Q2 2022 | $100,000 | -45.1% | 103,980 | 0.0% | 0.01% | -42.9% |
| Q1 2022 | $182,000 | -23.5% | 103,980 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $238,000 | -56.7% | 103,980 | 0.0% | 0.01% | -36.4% |
| Q3 2021 | $550,000 | -18.6% | 103,980 | 0.0% | 0.02% | -4.3% |
| Q2 2021 | $676,000 | -24.5% | 103,980 | 0.0% | 0.02% | +15.0% |
| Q1 2021 | $895,000 | +33.8% | 103,980 | 0.0% | 0.02% | +25.0% |
| Q4 2020 | $669,000 | -61.9% | 103,980 | -68.4% | 0.02% | -76.1% |
| Q2 2020 | $1,757,000 | -48.6% | 328,980 | -3.7% | 0.07% | -57.9% |
| Q1 2020 | $3,416,000 | +26.3% | 341,618 | +35.2% | 0.16% | +47.2% |
| Q4 2019 | $2,704,000 | -75.9% | 252,747 | -71.3% | 0.11% | -84.2% |
| Q3 2019 | $11,206,000 | -16.1% | 881,681 | -1.0% | 0.68% | -11.1% |
| Q2 2019 | $13,356,000 | +203.5% | 890,387 | +252.3% | 0.77% | +158.2% |
| Q1 2019 | $4,400,000 | – | 252,749 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,109,000 | 3.48% |
| SV Health Investors, LLC | 311,490 | $2,109,000 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 1,648,485 | $11,160,000 | 1.04% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,268,000 | 0.91% |
| Ikarian Capital, LLC | 724,680 | $4,907,000 | 0.36% |
| BVF INC/IL | 792,892 | $5,368,000 | 0.29% |
| Opaleye Management Inc. | 75,000 | $508,000 | 0.10% |
| Orbimed Advisors | 1,086,493 | $7,356,000 | 0.09% |
| RA Capital Management | 559,494 | $3,788,000 | 0.07% |
| Bleichroeder LP | 35,730 | $242,000 | 0.04% |